Cite
Progressive symmetrical erythrokeratoderma: report of two Chinese families and evaluation for mutations in the loricrin, connexin 30.3 and connexin 31 genes.
MLA
Guo, B. ‐. R., et al. “Progressive Symmetrical Erythrokeratoderma: Report of Two Chinese Families and Evaluation for Mutations in the Loricrin, Connexin 30.3 and Connexin 31 Genes.” Clinical & Experimental Dermatology, vol. 38, no. 8, Dec. 2013, pp. 925–27. EBSCOhost, https://doi.org/10.1111/ced.12135.
APA
Guo, B. ‐ R., Sun, L. ‐ D., Cui, Y., Yang, S., & Zhang, X. ‐ J. (2013). Progressive symmetrical erythrokeratoderma: report of two Chinese families and evaluation for mutations in the loricrin, connexin 30.3 and connexin 31 genes. Clinical & Experimental Dermatology, 38(8), 925–927. https://doi.org/10.1111/ced.12135
Chicago
Guo, B. ‐ R., L. ‐ D. Sun, Y. Cui, S. Yang, and X. ‐ J. Zhang. 2013. “Progressive Symmetrical Erythrokeratoderma: Report of Two Chinese Families and Evaluation for Mutations in the Loricrin, Connexin 30.3 and Connexin 31 Genes.” Clinical & Experimental Dermatology 38 (8): 925–27. doi:10.1111/ced.12135.